摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(2S,5R)-7-oxo-6-phenylmethoxy-1,6-diazabicyclo[3.2.1]octan-2-yl]formamide

中文名称
——
中文别名
——
英文名称
N-[(2S,5R)-7-oxo-6-phenylmethoxy-1,6-diazabicyclo[3.2.1]octan-2-yl]formamide
英文别名
——
N-[(2S,5R)-7-oxo-6-phenylmethoxy-1,6-diazabicyclo[3.2.1]octan-2-yl]formamide化学式
CAS
——
化学式
C14H17N3O3
mdl
——
分子量
275.3
InChiKey
MAVIXFADDCZYQG-OLZOCXBDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    61.9
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • NITROGEN CONTAINING COMPOUNDS AND THEIR USE
    申请人:Patil Vijaykumar Jagdishwar
    公开号:US20140088070A1
    公开(公告)日:2014-03-27
    Compounds of Formula (I), their preparation and use in preventing or treating bacterial infections are disclosed.
    公式(I)的化合物、它们的制备以及在预防或治疗细菌感染中的应用被披露。
  • METHOD FOR PREPARING AVIBACTAM INTERMEDIATE
    申请人:Xinfa Pharmaceutical Co., Ltd
    公开号:EP3543236A1
    公开(公告)日:2019-09-25
    The present invention discloses a method for preparing an intermediate for avibactam, and specifically relates to a method for preparing ([(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl]oxy}sulfonyl)tetrabutylammo nium salt (II). With 5R- [(benzyloxy) amino] piperidine-2S- carboxylate oxalate (III) as the raw material is reacted with the amide of Formula IV via amidation to prepare the compound of Formula V; the resulting compound of Formula V is reacted with the carbonylation reagent via urea cyclization to obtain the compound of Formula VI; the benzyl or the substituted benzyl in the compound of Formula VI is removed by catalytic hydro generation, then the resulting compound is sulfatated by sulfur trioxide complex and is salinized into tetrabutylammonium to obtain the final product (II). The reaction condition for the process of the present application is easily operable; the preparing process has a strong operability, a simple process, a low cost, less byproducts, and a high reaction atomic economy; the obtained product (II) has a high purity and a high yield.
    本发明公开了一种阿维菌素中间体的制备方法,具体涉及一种制备([(2S,5R)-2-基甲酰基-7-氧代-1,6-二氮杂双环[3.2.1]辛-6-基]氧基}磺酰基)四丁基铵盐(II)的方法。以 5R-[(苄氧基)基]哌啶-2S-羧酸草酸盐(III)为原料,通过酰胺化反应与式 IV 的酰胺反应,制备式 V 的化合物;得到的式 V 的化合物通过环化反应与羰基化试剂反应,得到式 VI 的化合物;通过催化加氢脱除式 VI 化合物中的苄基或取代苄基,然后用三氧化硫络合物对所得化合物进行 酸化,并盐析成四丁基,得到最终产物(II)。本申请工艺的反应条件易于操作;制备过程可操作性强,工艺简单,成本低,副产物少,反应原子经济性高;得到的产物(II)纯度高,收率高。
  • Process for preparing an intermediate for avibactam
    申请人:XINFA PHARMACEUTICAL CO., LTD
    公开号:US10570132B2
    公开(公告)日:2020-02-25
    A method for preparing an intermediate for avibactam, and specifically relates to a method for preparing ([(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl]oxy}sulfonyl)tetrabutylammonium salt (II). With 5R-[(benzyloxy) amino] piperidine-2S-carboxylate oxalate (III) as the raw material is reacted with the amide of Formula IV via amidation to prepare the compound of Formula V; the resulting compound of Formula V is reacted with the carbonylation reagent via urea cyclization to obtain the compound of Formula VI; the benzyl or the substituted benzyl in the compound of Formula VI is removed by catalytic hydrogeneration, then the resulting compound is sulfatated by sulfur trioxide complex and is salinized into tetrabutylammonium to obtain the final product (II).
    一种制备阿维巴坦中间体的方法,具体涉及一种制备([(2S,5R)-2-基甲酰基-7-氧代-1,6-二氮杂双环[3.2.1]辛-6-基]氧基}磺酰基)四丁基铵盐(II)的方法。以 5R-[(苄氧基)基]哌啶-2S-羧酸草酸盐(III)为原料,通过酰胺化反应与式 IV 的酰胺反应,制备式 V 的化合物;得到的式 V 的化合物通过环化反应与羰基化试剂反应,得到式 VI 的化合物;通过催化加氢脱除式 VI 化合物中的苄基或取代的苄基,然后用三氧化硫络合物对所得化合物进行 酸化,并盐析成四丁基,得到最终产物 (II)。
  • PROCESS FOR PREPARING AN INTERMEDIATE FOR AVIBACTAM
    申请人:XINFA PHARMACEUTICAL CO., LTD
    公开号:US20190263812A1
    公开(公告)日:2019-08-29
    A method for preparing an intermediate for avibactam, and specifically relates to a method for preparing ([(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl]oxy}sulfonyl)tetrabutylammonium salt (II). With 5R-[(benzyloxy) amino] piperidine-2S-carboxylate oxalate (III) as the raw material is reacted with the amide of Formula IV via amidation to prepare the compound of Formula V; the resulting compound of Formula V is reacted with the carbonylation reagent via urea cyclization to obtain the compound of Formula VI; the benzyl or the substituted benzyl in the compound of Formula VI is removed by catalytic hydrogeneration, then the resulting compound is sulfatated by sulfur trioxide complex and is salinized into tetrabutylammonium to obtain the final product (II).
  • US8754102B2
    申请人:——
    公开号:US8754102B2
    公开(公告)日:2014-06-17
查看更多

同类化合物

(4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) 高哌嗪-1,4-双(2-乙磺酸) 高哌嗪 苏沃雷生中间体3 胍1,5-二氮杂二环(5.4.0)十一烷 环丁基(1,4-二氮杂环庚-1-基)甲酮 新型Β内酰胺酶抑制剂WTM-12-00A(NEW) 叔-丁基6,6-二氟-1,4-重氮基庚环-1-甲酸基酯 十氢吡嗪并[1,2-d][1,4]二氮杂卓 六氢-1-(4-哌啶基)-5H-1,4-二氮杂卓-5-酮 六氢-1,4-二[2-(4-吡啶基)乙基]-1H-1,4-二氮杂卓 六氢-1,4-二[2-(2-吡啶基)乙基]-1H-1,4-二氮杂卓 六氢-1,2,2,7,7-五甲基-1H-1,4-二氮杂卓 二氢-吡啶并[1,2-A][1,4]二噁杂英 二乙基3,3'-(1,4-二氮杂环庚-1,4-二基)二丙酸酯 二-叔-丁基6-氧亚基-1,4-重氮基庚环-1,4-二甲酸基酯 [1,4]二氮杂环庚烷-6-胺 [1,4]二氮杂烷-1-羧酸叔丁酯盐酸盐 NACUBACTAM中间体2 N-甲基高哌嗪盐酸盐 N-甲基高哌嗪 N-乙氧羰基高哌嗪 N-丁基高哌嗪 N-丁基-7,8,9,10-四氢-6H-环庚三烯并[b]喹啉-11-胺盐酸(1:1) N-[3-(3,4,5,7,8,9,10,10a-八氢吡啶并[1,2-a][1,4]二氮杂卓-2(3H)-基)丙基]-胍 N-[2-(1,4-二氮杂环庚烷-1-基)乙基]-N,N-二乙胺 N,N’-二(3-羟基丙基)高哌嗪 N,N-二亚硝基高哌嗪 N,N'-亚丁基脲 N,N'-二甲基四亚甲基硫脲 N(1),N(4)-二-(gamma-氯-beta-羟基丙基)六氢-1,4-二氮杂卓 9-甲基-3,9-二氮杂双环[4.2.1]壬烷-4-酮 9-甲基-3,9-二氮杂双环[4.2.1]壬烷 8-(4-吡啶基)-1,5-二氮杂双环[3.2.1]辛烷 8,9-二氮杂五环[5.4.0.02,6.03,11.04,10]十一烷 7-甲基-1,4-二氮杂烷-1-羧酸叔丁酯 6-羟基甲基-[1,4]二氮杂烷-1-羧酸叔丁酯 6-羟基-1,4-二氮杂烷-1-羧酸叔丁酯 6-甲基-3,6-二氮杂双环[3.2.0]庚烷 6-甲基-1,7-二氮杂双环[4.1.0]庚烷 6-甲基-1,4-二氮杂环庚烷 6-环丁基-3,6-二氮杂双环[3.2.1]-2-辛酮 6-氟-1,4-二氮杂环庚烷 6-Boc-3,6-二氮杂双环[3.2.0]庚烷 6,6-二氟-1,4-二氮杂环庚烷 5-甲基-1,4-二氮杂环庚烷-1-甲酰基叔丁酯 5-甲基-1,4-二氮杂环庚烷 5-乙基-1,3-二氮杂环庚-2,4,7-三酮 4-苄基-1-{[6-(三氟甲基)-3-吡啶基]甲基}-1,4-二氮杂环庚-5-酮